Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20101
20111
20121
20182
20193
20202
20211
20222
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Terminated4
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals3
BeiGene2
AIO-Studien-gGmbH1
AstraZeneca1
Daiichi Sankyo1
Federation Francophone de Cancerologie Digestive1
Hoffmann-La Roche1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Merus B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma22
Esophageal Neoplasms6
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Stomach Neoplasms2
Triple Negative Breast Neoplasms2
Carcinoma, Hepatocellular1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.